Skip to main content
. 2019 Mar 1;10(18):1669–1687. doi: 10.18632/oncotarget.26707

Figure 4. Kaplan–Meier curves assuming the survival in high risk patients and low-risk patients.

Figure 4

(A) Progression free survival associated with selected baseline clinical variables (sex and presence of brain metastasis). (B) Overall survival associated with selected baseline clinical variables (sex and presence of brain metastasis). (C) Progression free survival associated with gene expression only. (D) Overall survival associated with gene expression only. (E) Progression free survival associated with gene expression adjusted on selected clinical variables. (F) Overall survival associated with gene expression adjusted on selected clinical variables. Log-rank tests were performed to compute P-values. (OS: Overall survival; PFS: Progression free survival).